• All
  • Primary Antibodies
  • Conjugated Antibodies for IF
  • Conjugated Antibodies for FC
  • Secondary Antibodies
  • Antibody Labeling KitsNew
  • ELISA Kits
  • IHC Kits
  • Magnetic Cell Separation Kits
  • Cytokines & Growth Factors
  • Neutralizing/activating Antibodies
  • Nanobody-based Reagents
  • Accessory Products and Kits
  • Fusion Proteins
×
×
Host
0
Species Reactivity
0
Species Reactivity
0
Conjugate
0
Conjugate
0
Compatible Species
0
Conjugate
0
  • Featured Product
  • KD/KO Validated

EGFL7 Polyclonal antibody

EGFL7 Polyclonal Antibody for ELISA

Host / Isotype

Rabbit / IgG

Reactivity

human and More (2)

Applications

WB, IF, IHC, ELISA

Conjugate

Unconjugated

Cat no : 19291-1-AP

Synonyms

EGF like domain, multiple 7, EGF like protein 7, EGFL7, MEGF7, NOTCH4 like protein, RP11 251M1.2, Vascular endothelial statin, VE STATIN, ZNEU1

Validation Data Gallery

Filter:
  • Immunohistochemistry (IHC) staining of human breast cancer tissue using EGFL7 Polyclonal antibody (19291-1-AP)

    IHC staining of human breast cancer using 19291-1-AP

    Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 19291-1-AP (EGFL7 Antibody) at dilution of 1:50 (under 10x lens).

  • Immunohistochemistry (IHC) staining of human breast cancer tissue using EGFL7 Polyclonal antibody (19291-1-AP)

    IHC staining of human breast cancer using 19291-1-AP

    Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 19291-1-AP (EGFL7 Antibody) at dilution of 1:50 (under 40x lens).

  • Immunohistochemistry (IHC) staining of human ovary tumor tissue using EGFL7 Polyclonal antibody (19291-1-AP)

    IHC staining of human ovary tumor using 19291-1-AP

    Immunohistochemical analysis of paraffin-embedded human ovary tumor tissue slide using 19291-1-AP (EGFL7 Antibody) at dilution of 1:50 (under 10x lens).

  • Immunohistochemistry (IHC) staining of human ovary tumor tissue using EGFL7 Polyclonal antibody (19291-1-AP)

    IHC staining of human ovary tumor using 19291-1-AP

    Immunohistochemical analysis of paraffin-embedded human ovary tumor tissue slide using 19291-1-AP (EGFL7 Antibody) at dilution of 1:50 (under 40x lens).

  • Immunohistochemistry (IHC) staining of human endometrial cancer tissue using EGFL7 Polyclonal antibody (19291-1-AP)

    IHC staining of human endometrial cancer using 19291-1-AP

    Immunohistochemical analysis of paraffin-embedded human endometrial cancer tissue slide using 19291-1-AP (EGFL7 Antibody) at dilution of 1:50 (under 10x lens).

  • Immunohistochemistry (IHC) staining of human endometrial cancer tissue using EGFL7 Polyclonal antibody (19291-1-AP)

    IHC staining of human endometrial cancer using 19291-1-AP

    Immunohistochemical analysis of paraffin-embedded human endometrial cancer tissue slide using 19291-1-AP (EGFL7 Antibody) at dilution of 1:50 (under 40x lens).

Product Information

The immunogen of 19291-1-AP is EGFL7 Fusion Protein expressed in E. coli.

Tested Reactivity human
Cited Reactivityhuman, mouse, rat
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen EGFL7 fusion protein Ag6559
Full Name EGF-like-domain, multiple 7
Calculated Molecular Weight 273 aa, 30 kDa
GenBank Accession NumberBC012377
Gene Symbol EGFL7
Gene ID (NCBI) 51162
RRIDAB_10643993
Conjugate Unconjugated
Form Liquid
Purification MethodAntigen affinity purification
Storage Buffer PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
Storage ConditionsStore at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.

Background Information

Epidermal growth factor-like domain-containing protein 7 (EGFL7), also known as vascular endothelial statin, is an endothelial cell-derived secreted factor that regulates vascular tube formation. This protein may be involved in the growth and proliferation of tumor cells. Recent studies have reported elevated expression of EGFL7 in several tumors and cancer cell lines, including kidney tumors, malignant gliomas, hepatocellular carcinomas, and colon cancers.

Protocols

Product Specific Protocols
IHC protocol for EGFL7 antibody 19291-1-APDownload protocol
Standard Protocols
Click here to view our Standard Protocols

Publications

SpeciesApplicationTitle
humanWB

Blood Adv

The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models.

Authors - Yousef Salama
  • KD Validated
View Article
humanWB

Mol Ther Nucleic Acids

Role of ANKHD1/LINC00346/ZNF655 Feedback Loop in Regulating the Glioma Angiogenesis via Staufen1-Mediated mRNA Decay.

Authors - Chunqing Yang
View Article
humanWB,IHC,IF

Front Oncol

Novel Expression of EGFL7 in Osteosarcoma and Sensitivity to Cisplatin.

Authors - Qing Liu
View Article
mouse,ratWB

Sci China Life Sci

Role of EGFL7/EGFR-signaling pathway in migration and invasion of growth hormone-producing pituitary adenomas.

Authors - Qian Liu
View Article
humanWB

Hum Gene Ther

Attenuation of EGFL7 expression inhibits growth hormone-producing pituitary adenomas growth and invasion.

Authors - Qian Liu
View Article
humanWB,IHC

Tumour Biol

EGFL7 participates in regulating biological behavior of growth hormone-secreting pituitary adenomas via Notch2/DLL3 signaling pathway.

Authors - Jianpeng Wang
View Article